Unknown

Dataset Information

Depression and Suicidal Ideation Among HIV-Infected Adults Receiving Efavirenz Versus Nevirapine in Uganda: A Prospective Cohort Study.


ABSTRACT:

Background

Evidence regarding potential adverse neuropsychiatric effects of efavirenz is conflicting, and data from sub-Saharan Africa, where 70% of persons living with HIV (PLHIV) reside and efavirenz is used as first-line therapy, are limited.

Objective

To estimate associations between efavirenz use and depression and suicidal ideation among PLHIV in Uganda.

Design

Prospective observational cohort study. (ClinicalTrials.gov: NCT01596322).

Setting

Mbarara, Uganda.

Participants

Adult PLHIV enrolled at the start of antiretroviral therapy (ART) and observed every 3 to 4 months from 2005 to 2015.

Measurements

The exposure of interest was time-varying efavirenz use, defined as use during the 7 days and in 60 or more of the 90 days before a study visit

SUBMITTER: Chang JL 

PROVIDER: S-EPMC6475600 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature